Skip to content

Monocyte dysfunction in Multiple Sclerosis (MS)

Monocyte dysfunction in Multiple Sclerosis (MS) - Monocyte dysfunction in Multiple Sclerosis (MS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36307
Enrollment
40
Registered
2011-03-29
Start date
2011-06-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Primary progressive MS, secondary progressive MS and Relapsing/Remitting MS

Exclusion criteria

Exclusion criteria: Not applicable

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)